PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsNewsNon-hormonal male pill successful in animal studies

BioNews

Non-hormonal male pill successful in animal studies

Published 4 December 2012 posted in News and appears in BioNews 669

Author

Daryl Ramai

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.

Scientists may now be one step closer to producing the first non-hormonal, male contraceptive pill after a successful animal study...

Scientists may now be one
step closer to producing the first non-hormonal, male contraceptive pill after
a successful animal study.

The study, published
in the journal Cell, claims that a compound called JQ1 is able to disrupt
spermatogenesis - the maturing of sperm - in male mice as it crosses from the
blood to the testis.

'Our
findings demonstrate that, when given to rodents, this compound produces a
rapid and reversible decrease in sperm count and mobility with profound effects
on fertility', said Dr
James Bradner, senior author of the study at the Dana-Farber Cancer Institute
in Boston, USA.

The researchers showed
that JQ1 works by inhibiting BRDT, a protein critical to fertility that
instructs germ cells to grow into sperm cells. The result is a decrease in the
number and quality of sperm, without any affect to the hormonal system and
libido.

'There is no effect on the
mouse's mojo. The animals exhibit the normal sexual behaviours and frequency of
copulation', said Dr Bradner.

The study also showed that when the
drug treatment was discontinued, sperm production and fertility was restored to
normal levels.

'To date, most of the trials have attempted to
stop sperm production by manipulating the male hormone testosterone through the
use of injections or implants', explained Dr Allan Pacey, senior lecturer in
andrology at the University of Sheffield.

However, hormone
treatments can have serious side effects. 'Non-hormonal targets are urgently
needed', said Dr Bradner.

Professor William
Bremner, of the University of Washington in Seattle and who was not involved in
the study, told ABC News that since the development of condoms centuries ago, there has
not been a new reversible contraceptive for men.

Though the drug
offers promising evidence for the development of an oral pill for human
contraception, Dr Bradner and colleagues are aware of the challenges in developing
a new product for human use.

Professor
Robert McLachlan, Director of Clinical Research at Prince Henry's Institute of
Medical Research in Melbourne, Australia said further studies in animals would
need to be performed before it could be trialled in men.

Talking to ABC News, he said: 'The development of a potential contraceptive is
a very long and arduous process leading up to the first human studies. It will be fascinating to see how the drug evolves, but we know that
such pipelines may require 15 years of evaluation and there are many potential
pitfalls along the journey'.

Related Articles

PET BioNews
News
6 December 2013 • 2 minutes read

Male pill on horizon

by Dr Katie Howe

A reversible way of stopping sperm cells being ejaculated has been identified in mice. The research could pave the way for the development of a male contraceptive pill...

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
News
13 March 2013 • 1 minute read

Male contraceptive lotion in early tests

by Dr Antony Starza-Allen

Researchers in the USA have claimed to have created a male contraceptive gel applied directly to the skin that can effectively reduce a man's sperm count with few side effects...

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
News
28 February 2013 • 1 minute read

Sperm-production gene could hold the key to developing a male pill

by Dr Rosie Morley

A non-hormonal male contraceptive pill could be developed by blocking a newly identified gene involved in the final stages of sperm production, according to scientists...

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
News
28 September 2012 • 1 minute read

Adding missing protein 'kick-starts' infertile sperm in lab tests

by Daryl Ramai

Adding a missing protein to infertile human sperm gives the sperm the ability to successfully fertilize an egg, a lab-based study reports...

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
News
7 December 2009 • 1 minute read

Hormonal 'on/off switch' may lead to male 'pill' and infertility cure

by Heidi Colleran

A team of scientists has taken male fertility research a major step forward, with the discovery of how androgenic hormones regulate the production of sperm in the testes of mice. The breakthrough, reported in the journal The Federation of American Societies for Experimental Biology (FASEB), may lead to greater understanding and control of male fertility, including the development of a male contraceptive 'pill', and treatments for infertility....

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
News
27 July 2009 • 2 minutes read

Discovery of gene mutation in sperm could lead to a male contraceptive pill

by Dr Antony Starza-Allen

Scientists have discovered a genetic mutation that could path the way for the development of new infertility treatments and also a male contraceptive pill. The mutation affects a protein called PLC zeta found in sperm which is responsible for activating an egg in the early stages of fertilisation. The study revealed that in cases where this protein was deactivated the sperm was not able to fertilise the egg....

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
News
9 June 2009 • 2 minutes read

Largest ever trial brings male contraceptive jab a step closer

by Heidi Colleran

By Heidi Colleran: Scientists in China have completed the largest ever trial to assess the effectiveness of a male hormonal contraceptive, which showed it achieved a 99 per cent success rate over the two and a half years of the study. Researchers at the National Research Institute for Family Planning...

Leave a Reply Cancel reply

You must be logged in to post a comment.

« Mammograms may increase risk of breast cancer in some women

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.

Find out how you can advertise here
easyfundraising
amazon

This month in BioNews

  • Popular
  • Recent
8 August 2022 • 2 minutes read

Placenta and organ formation observed in mouse embryo models

8 August 2022 • 2 minutes read

Lower hormone doses may improve IVF egg quality

8 August 2022 • 2 minutes read

Boosting muscle cell production of gene therapy proteins

1 August 2022 • 2 minutes read

First UK medical guidelines issued for trans fertility preservation

1 August 2022 • 2 minutes read

Male age has more impact on IVF birth rate than previously thought

15 August 2022 • 2 minutes read

Call to end ban on HIV-positive partner gamete 'donation'

15 August 2022 • 2 minutes read

Melanoma invades new tissues using nerve cell gene

15 August 2022 • 2 minutes read

Exceeding alcohol limits could damage DNA and accelerate ageing

15 August 2022 • 2 minutes read

Blood cell gene mutations affect mitochondria, increasing cardiovascular disease risk

15 August 2022 • 2 minutes read

Jumping gene helps immune system fight viruses

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856